Concepedia

Randomised Phase II study of oral lapatinib combined with chemoradiotherapy in patients with advanced squamous cell carcinoma of the head and neck: Rationale for future randomised trials in human papilloma virus-negative disease

Kevin J. Harrington, A. Berrier, Martin Robinson, Éva Remenár, Martin Housset, Fernando Hurtado de Mendoza, Jérôme Fayette, Hisham Mehanna, Iman El‐Hariry, Natalie Compton,

European Journal of Cancer · 2012 · 118 citations · 8 references

DOI

Concepts

References

8

The Mutational Landscape of Head and Neck Squamous Cell Carcinoma

Nicolas Stransky, Ann Marie Egloff, Aaron D. Tward et al. · Science · 2011 · 2.5K citations · Full text

, , +17

Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival

James A. Bonner, Paul M. Harari, J. Giralt et al. · The Lancet Oncology · 2009 · 2K citations

, , +13

The Relationship Between Human Papillomavirus Status and Other Molecular Prognostic Markers in Head and Neck Squamous Cell Carcinomas

Christina S. Kong, Balasubramanian Narasimhan, Hongbin Cao et al. · International Journal of Radiation Oncology*Biology*Physics · 2009 · 216 citations · Full text

, , +14

New Strategies in Head and Neck Cancer: Understanding Resistance to Epidermal Growth Factor Receptor Inhibitors

Lucy F. Chen, Ezra E.W. Cohen, Jennifer R. Grandis · Clinical Cancer Research · 2010 · 117 citations · Full text

, , +15

Epidermal Growth Factor Receptor Inhibitor Gefitinib Added to Chemoradiotherapy in Locally Advanced Head and Neck Cancer

Ezra E.W. Cohen, Daniel J. Haraf, Rangesh Kunnavakkam et al. · Journal of Clinical Oncology · 2010 · 85 citations · Full text

, , +15